Conditions: Parkinson's Disease
Keywords: SPM 962 rotigotine Parkinson's disease monotherapy
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 143
Healthy volunteers: no

Brief summary:
Safety of SPM 962 in a once-daily repeated long-term treatment in Parkinson's disease patients who are not concomitantly treated with L-dopa will be investigated with a doses.

Detailed description:

Arms:
arm 1: SPM 962 transdermal patch

Interventions: intervention 1: SPM 962
Intervention descriptions: intervention 1: SPM 962 transdermal patch once a daily up to 36.0 mg/day

Protocol document: